Home › NDC Lookup › Ingredients › Sennosides › 70000-0477-01
Leader Regular Strength Chocolate Laxative sennosides 15 mg Tablet, 24-count — NDC 70000-0477-01 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Leader Regular Strength Chocolate Laxative sennosides 15 mg Tablet, 24-count — NDC 70000-0477-1 (Billing 70000-0477-01)

by CARDINAL HEALTH · 2 POUCH in 1 CARTON / 12 TABLET in 1 POUCH

This is a package of 24 tablets of Leader Regular Strength Chocolate Laxative sennosides 15 mg Tablet from CARDINAL HEALTH, marketed since Jan 2019 and currently FDA-listed; retail pharmacies pay about $0.1063 per tablet (NADAC). It is this product's only package size.

NDC 70000-0477-01
🏷️ FDA NDC (as labeled) 70000-0477-1 billing pads the package segment with a zero
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 70000-0477-1
Product NDC 70000-0477
11-digit billing NDC 70000047701
NCPDP billing unit EA — each (per item)
RxCUI 251020
UNII 3FYP5M0IJX
UPC 0096295136722
Application # M007
SPL Set ID 1b7d8486-5b3b-44b7-a7b4-63ee2b836d6e
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2019-01-01
Route ORAL
Dosage form TABLET
Substance SENNOSIDES

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GPI-14 46200060200515
GPI class Chocolated Laxative
GCN Seq No 039784
GCN 12162
HICL code 001289
Ingredient (HICL) Sennosides
HIC1 code D
Therapeutic class — broad (HIC1) Biliary System/Gastro-Intestinal System
HIC2 code D6
Therapeutic class — intermediate (HIC2) Drugs Acting Principally On The Colon
HIC3 code D6S
Therapeutic class — specific (HIC3) Laxatives And Cathartics
AHFS code 56:12.00.00
AHFS class Cathartics And Laxatives
FDB label name CHOCOLATED LAXATIVE
FDB brand name Chocolated Laxative
Legend status O — Over-the-counter (OTC) drug or device
Quick answers
  • GSN (GCN sequence number): 039784
  • GCN: 12162
  • GPI-14 (Medi-Span): 46200060200515
  • HICL (First Databank): 001289
  • AHFS class code: 56:12.00.00
  • RxCUI (RxNorm): 251020
Why two NDCs? The FDA registers this code as 70000-0477-1 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 70000-0477-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Contact laxatives class.

Drug family (ATC) Contact laxatives
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

Label name CHOCOLATED LAXATIVE Ingredient Sennosides
📖 What it is MedlinePlus · NLM

Senna is used on a short-term basis to treat constipation. It also is used to empty the bowels before surgery and certain medical procedures. Senna is in a class of medications called stimulant laxatives. It works by increasing activity of the intestines to cause a bowel movement.

Read the full MedlinePlus article ↗
📗 Our plain-language guide HelloPharmacist
  • Senna typically produces a bowel movement within 6 to 12 hours. That's why most people take it at bedtime — so it can do its job overnight and you get results in the morning. If no...
  • How long does it take for senna to work?
  • Senna is designed for short-term, occasional use. You should not use it for more than 1 week unless your doctor specifically tells you it's okay. Using laxatives too often or for t...
  • Laxatives like senna can affect how your body absorbs other medications. To be safe, take senna at least 2 hours before or after any other drugs you use. It's always a good idea to...
📖 Read our full Senna guide →
3
Nutrient depletion considerations

Sennosides (OTC drug) may be associated with lower levels of 3 nutrients — worth a chat with your pharmacist, not a cause for alarm.

🧪 Full Sennosides (OTC drug) nutrient depletion report →
An association is not a deficiency. Educational only — don't start or stop anything without professional guidance.
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eaPer package
Retail pharmacies payNADAC · weekly $0.106 $2.55 / 24 tablets
Medicaid paysCMS SDUD · 12 mo $0.3150 $7.56 / 24 tablets
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
NADAC price history (per ea) — tap or hover for the price & month
Dec 2021 Jul 2022 Jan 2026 Jul 2026 $0.106 $0.092
▲ Up 7% over the last 12 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
70000-0477-01 You're viewing this Main listing 2 POUCH in 1 CARTON / 12 TABLET in 1 POUCH 2019-01-01 — Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Laxative 15 mg 70000-0443-01 Cardinal 15 tablets $0.067 — Availability likely save 37%
Chocolated Laxative 15 mg 63868-0266-24 C.D.M.A., 12 tablets $0.099 — FDA listed save 7%
Leader Regular Strength Chocolate Laxative sennosides 15 mgthis 70000-0477-01 CARDINAL 24 tablets $0.106 — Availability likely —
Ex-Lax Regular Strength Chocolated Stimulant Laxative 15 mg 00067-8140-01 Haleon 12 tablets — — FDA listed —
Chocolated Laxative 15 mg 00363-5000-24 Walgreens 12 tablets — — FDA listed —
Chocolated Laxative Regular Strength Sennosides Stimulant Laxative TopCare health 15 mg 36800-0994-01 Topco 12 tablets — — FDA listed —
Chocolate Laxative Regular strength, Sennosides Stimulant Laxative, equate 15 mg 49035-0349-24 Wal-Mart 12 tablets — — FDA listed —
Chocolated Laxative Regular Strength Sennosides Stimulant Laxative, DG health 15 mg 55910-0365-12 Dolgencorp 12 tablets — — FDA listed —
Chocolated Laxative Regular Strength Sennosides Stimulant Laxative, Best Choice 15 mg 63941-0980-24 Valu 12 tablets — — FDA listed —
Sennosides 15 mg 79481-0860-01 Meijer, 24 tablets — — FDA listed —
Equaline Regular Strength Chocolated Stimulant Laxative 15 mg 83455-0300-24 United 24 tablets — — FDA listed —
Laxative Regular Strength 15 mg 69842-0347-01 CVS 15 tablets — — FDA listed —
Laxative Regular Strength 15 mg 37835-0214-45 Bi-Mart 15 tablets — — FDA listed —
Ex-Lax Regular Strength Stimulant Laxative 15 mg 00067-8141-01 Haleon 8 tablets — — FDA listed —
Stimulant Laxative 15 mg 51316-0734-01 CVS 15 tablets — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2019
On the market since
Jan 2019
📍
2026
Currently FDA-listed
7 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

What it looks like

Color brown
ShapeSquare
ImprintCL
Size68 mm
FlavorChocolate
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII D9108TZ9KG
    Cocoa is a natural powder made from roasted cacao beans. It's used as a flavoring and coloring agent to make medicines taste better and appear brown.

1 inactive ingredient listed in the exact product block matched to this NDC.

The official label also statescocoa powder, hydrogenated vegetable oils (palm, palm kernel), salt, soy lecithin (an emulsifier), sugar, vanilla, and whey powder (milk)

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerCARDINAL HEALTH
FDA applicationM007 (OTC MONOGRAPH DRUG)
Labeler code70000
First marketedJan 2019
Product typeHuman Otc Drug
Portfolio84 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Do Not Use 📄 Ask a Doctor Before Use If 📄 Ask a Doctor or Pharmacist Before Use If 📄 When Using This Product 📄 Stop Use and Ask a Doctor If 🤰 If Pregnant or Breast-Feeding 📄 Keep Out of Reach of Children 📄 Other Information 📄 Questions or Comments 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 14 words ▾

Uses relieves occasional constipation (irregularity) generally produces bowel movement in 6 to 12 hours

⏱️ Dosage and Administration 43 words ▾

Directions adults and children 12 years of age and older chew 2 chocolated pieces once or twice daily children 6 to under 12 years of age chew 1 chocolated piece once or twice daily children under 6 years of age ask a doctor

⚠️ Warnings 151 words ▾

Warnings Do not use laxative products when abdominal pain, nausea or vomiting are present unless directed by a doctor Ask a doctor before use if you have noticed a sudden change in bowel habits that persists over a period of 2 weeks Ask a doctor or pharmacist before use if you are taking any other drug. Laxatives may affect how other drugs work. Take this product 2 or more hours before or after other drugs.

When using this product do not use for a period longer than 1 week Stop use and ask a doctor if rectal bleeding or failure to have a bowel movement occur after use of a laxative. These may be signs of a serious condition. If pregnant or breastfeeding, ask a health professional before use.

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

🧪 Active Ingredient 8 words ▾

Active ingredient (in each piece) Sennosides, 15 mg

🧪 Inactive Ingredients 21 words ▾

Inactive ingredients cocoa powder, hydrogenated vegetable oils (palm, palm kernel), salt, soy lecithin (an emulsifier), sugar, vanilla, and whey powder (milk)

🎯 Purpose 3 words ▾

Purpose Stimulant laxative

📄 Do Not Use 18 words ▾

Do not use laxative products when abdominal pain, nausea or vomiting are present unless directed by a doctor

📄 Ask a Doctor Before Use If 23 words ▾

Ask a doctor before use if you have noticed a sudden change in bowel habits that persists over a period of 2 weeks

📄 Ask a Doctor or Pharmacist Before Use If 33 words ▾

Ask a doctor or pharmacist before use if you are taking any other drug. Laxatives may affect how other drugs work. Take this product 2 or more hours before or after other drugs.

📄 When Using This Product 14 words ▾

When using this product do not use for a period longer than 1 week

📄 Stop Use and Ask a Doctor If 30 words ▾

Stop use and ask a doctor if rectal bleeding or failure to have a bowel movement occur after use of a laxative. These may be signs of a serious condition.

🤰 If Pregnant or Breast-Feeding 10 words ▾

If pregnant or breastfeeding, ask a health professional before use.

📄 Keep Out of Reach of Children 22 words ▾

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

📄 Other Information 12 words ▾

Other information each piece contains: potassium 10 mg store at 15°-25°C (59°-77°F)

📄 Questions or Comments 4 words ▾

Questions or comments? 1-877-586-7979

📄 Package Label / Principal Display Panel 51 words ▾

Principal Display Panel – Chocolated Laxative Carton Label LEADER ™ NDC 70000-0477-1 Regular Strength Chocolated Laxative Sennosides, USP, 15 mg | Stimulant Laxative Chocolate Flavored Relieves Occasional Constipation 24 PIECES Actual Size COMPARE TO ex•lax® REGULAR STRENGTH active ingredient* 100% Money Back Guarantee Principal Display Panel – Chocolated Laxative Carton Label

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicaid utilization & spend

📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for this package alone, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q1 2026 · 5 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
3.8K
Units reimbursed last 4 qtrs
124.4K
Gross reimbursed last 4 qtrs
$39.2K
Avg / prescription
$10.37
Avg / unit
$0.3150
Latest quarter Q1 2026
962Rx
Medicaid pays / ea
$0.3150
gross reimbursed
vs
NADAC / ea
$0.1063
acquisition cost
=
Spread
+$0.2087
+196% vs cost
What Medicaid paid per ea (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care ⓘ
29% FFS 71% MCO
Fee-for-service · 1,115 Rx Managed care · 2,665 Rx
State Medicaid map
Alaska: no data reported AK Maine: 576 units · 41.3 per 100k residents ME Washington: no data reported WA Idaho: no data reported ID Montana: no data reported MT North Dakota: no data reported ND Minnesota: no data reported MN Wisconsin: no data reported WI Michigan: 2,652 units · 26.4 per 100k residents MI New York: 16,107 units · 82.3 per 100k residents NY Vermont: 3,375 units · 522 per 100k residents VT New Hampshire: no data reported NH Oregon: no data reported OR Nevada: no data reported NV Wyoming: no data reported WY South Dakota: no data reported SD Iowa: no data reported IA Illinois: no data reported IL Indiana: no data reported IN Ohio: 49,558 units · 421 per 100k residents OH Pennsylvania: 16,846 units · 130 per 100k residents PA New Jersey: 3,694 units · 39.8 per 100k residents NJ Massachusetts: 9,963 units · 142 per 100k residents MA California: 1,724 units · 4.4 per 100k residents CA Utah: no data reported UT Colorado: no data reported CO Nebraska: 2,334 units · 118 per 100k residents NE Missouri: no data reported MO Kentucky: no data reported KY West Virginia: no data reported WV Virginia: 3,294 units · 37.8 per 100k residents VA Maryland: 2,303 units · 37.3 per 100k residents MD Connecticut: 5,488 units · 152 per 100k residents CT Rhode Island: no data reported RI Arizona: 2,403 units · 32.3 per 100k residents AZ New Mexico: no data reported NM Kansas: 4,095 units · 139 per 100k residents KS Arkansas: no data reported AR Tennessee: no data reported TN North Carolina: no data reported NC South Carolina: no data reported SC Delaware: no data reported DE Oklahoma: no data reported OK Louisiana: no data reported LA Mississippi: no data reported MS Alabama: no data reported AL Georgia: no data reported GA D.C.: no data reported DC Hawaii: no data reported HI Texas: no data reported TX Florida: no data reported FL
Units reimbursed · per 100k residents
4.4522
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
🏆 Top states by units · per 100k residents
1 Vermont 522 /100k
2 Ohio 421 /100k
3 Connecticut 152 /100k
4 Massachusetts 142 /100k
5 Kansas 139 /100k
6 Pennsylvania 130 /100k
7 Nebraska 118 /100k
8 New York 82.3 /100k
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Leader Regular Strength Chocolate Laxative sennosides (this brand).

Top reported reactions

Pain570
Pyrexia542
Asthma531
Fatigue530
Constipation526
Headache526
Dyspnoea506

Age at onset

Infant4
Child20
Adolescent22
Adult467
Elderly760

Reporter sex

5,698 reports
Male · 48%
Female · 52%
Unknown · 0%

Serious outcomes

Hospitalization3,129
Reports over time (by year) — tap or hover for the count & year
2021 2022 2024 2026 910 290
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.
← 70000-0475-01 · Cardinal 70000-0478-01 · Cardinal →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.